维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="SAMUDIO IJ"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy 显示文摘	Kensuke K Konopleva M Samudio IJ	2005	Blood2005，106，9：	1
2	Targeting the leukemia microenvironment by CXCR4 inhibition over- comes resistance to kinase inhibitors and chemotherapy in AML显示文摘	Zeng Z Shi YX Samudio IJ	2009	Blood2009，113，24：	1
3	Targeting theleukemia microenvironment by CXCR4 inhibitionovercomes resistance to kinase inhibitors andchemotherapy in AML 显示文摘	Zeng Z Shi YX Samudio IJ	2009	Blood2009，113，24：	1
4	MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy显示文摘	KOJIMA K KONOPLEVA M SAMUDIO IJ	2005	Blood2005，106，9：	1
5	Mitogen-activated protein kinase kinase inhibition enhances nuclear proapoptotic function of p53 in acute myelogenous leukemia cells显示文摘	Kojima K Konopleva M Samudio IJ	2007	Cancer Res2007，67，7：	1
6	Mdm2 antagonists induce p53-dependent apoptosis in AML:implications for leukemia therapy显示文摘	Kojima K Konopleva M Samudio IJ	2005	Blood2005，106，9：	1
7	Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML显示文摘	Zeng ZH Sarbassov DD Samudio IJ	2007	{H}Blood2007，，8：	1
8	Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML显示文摘	Zeng Z Sarbassov dos D Samudio IJ		0，，08：	1
9	Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML显示文摘	Zeng Z Shi YX Samudio IJ	2009	Blood2009，113，24：	1
10	Targeting the leukemia microenvironment by CXCR4inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML显示文摘	Zeng Z Shi YX Samudio IJ	2009	Blood2009，113，：	1
11	Targeting the leukemia micro-environment by CXCR4 inhibition overcomes resistance to kinase in-hibitors and chemotherapy in AML显示文摘	Zeng Z Shi YX Samudio IJ Wang RY Ling X Frolova O Levis M Rubin JB Negrin RR Estey EH	2009	Blood2009，113，：	1
12	Targeting the leukemia microenviroment by CXCR4inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML显示文摘	Zeng Z Shi YX Samudio IJ	2009	Blood2009，113，：	1
13	Rapamycin deriva- tives reduce mTORC2 signaling and inhibit AKT activa- tion in AML显示文摘	Zeng Z Sarbassov DD Samudio IJ et d	2007	Blood2007，109，8：	1
14	Activation p53signaling by MI-63 induces apoptosis in acute myeloid leukemia cells显示文摘	Samudio IJ Duwuri S Dwyer Clise-K	2010	Leuk diagnosed with lymphoma2010，51，5：	1
15	Mitogen-activated protein kinase kinase inhibition enhances nuclear proapoptotic function of p53 in acute myelogenous leukemia cells 显示文摘	Kojima K Konopleva M Samudio IJ	2007	Cancer Res2007，67，7：	1
16	Mitogen activated protein kinase kinase inhibition enhances nuclear proapoptotic function of p53 in acute myelogenous leukemia cells显示文摘	Kojima K Konopleva M Samudio IJ	2007	Cancer Res2007，67，7：	1
17	Targeting the leukemia micro- environment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML 显示文摘	Zeng Z Shi YX Samudio IJ	2009	Blood2009，113，24：	1
18	MDM2 antagonists induce p53-dependent apoptosis in AML:implications for leukemia therapy显示文摘	Kojima K Konopleva M Samudio IJ Shikami M Cabreira-Hansen M McQueen T	2005	Blood2005，106，9：	1
19	Rapamycin deriva tives reducemTORC2 signaling and inhibit AKT activation in AML显示文摘	Zeng Z Sarbassov dos D Samudio IJ	2007	Blood2007，109，8：	1
20	Inhibition of CXCR4 with the novel RCP168 peptide overcomes stromamediated chemoresistance in chronic and acute leukemias显示文摘	Zeng Z Samudio IJ Munsell M	2006	Mol Cancer Ther2006，5，12：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示